Skip to search formSkip to main contentSkip to account menu

MDA-MB-435

A cell line established at M.D. Anderson Cancer Center in 1976 from the pleural effusion of a 31 year old female patient with history of breast… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
MDA-MB-435 cell line has been used for decades as a model of metastatic human breast cancer [1]. This cell line was derived at M… 
Highly Cited
2007
Highly Cited
2007
Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
Highly Cited
2006
Highly Cited
2006
Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Bovine lactoferricin (LfcinB) is a cationic peptide that selectively induces caspase-dependent apoptosis in human leukemia and… 
Highly Cited
2006
Highly Cited
2006
Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism.
It has been well established that the restoration of connexin expression in tumor cells often leads to a partial reversion of… 
Highly Cited
2004
Highly Cited
2004
MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
Highly Cited
2003
Highly Cited
2003
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
The specificity of a novel epidermal growth factor (EGF)-Cy5.5 fluorescent optical probe in the detection of EGF receptor (EGFr… 
Highly Cited
2001
Highly Cited
2001
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit the growth of various cancers by mechanism(s) that include the… 
Highly Cited
2000
Highly Cited
2000
Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.
We previously showed that introduction of a normal, neomycin-tagged human chromosome 11 reduces the metastatic capacity of MDA-MB… 
Highly Cited
1999
Highly Cited
1999
Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.
Breast cancer is the most common cancer and second leading cause of cancer related deaths in women in the United States… 
Highly Cited
1996
Highly Cited
1996
Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.
To determine the relevance of genetic information on chromosome 11 in the development of metastatic breast tumors, we introduced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)